Jiangsu Anbison Pharmaceutical

Jiangsu Anbison Pharmaceutical is a specialty pharmaceutical company focused on the development, manufacturing, and commercialization of complex generic drugs and improved new drugs (Class 2). The company specializes in advanced drug delivery systems, particularly sustained-release and controlled-release formulations, including microsphere-coated tablets and matrix tablets. With manufacturing facilities in Taizhou and R&D centers in Shanghai, Anbison has successfully launched several products in China and the U.S., such as Felodipine Sustained Release Tablets and Carbamazepine Extended Release Tablets. The company maintains strategic partnerships with global firms like Sandoz and Ethypharm to expand its market reach and is recognized for its high-quality manufacturing standards, having passed U.S. FDA cGMP inspections.